Fortress Biotech, Inc. (FBIO) Net Income (Loss) Attributable to Parent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Fortress Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Fortress Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$15.4 M, a 28.4% increase year-over-year.
  • Fortress Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$54.5 M, a 41% increase year-over-year.
  • Fortress Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$60.6 M, a 30% increase from 2022.
  • Fortress Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$86.6 M, a 33.8% decline from 2021.
  • Fortress Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$64.7 M, a 39.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$54.5 M -$15.4 M +$6.12 M +28.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$60.6 M -$9.28 M +$17.7 M +65.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$78.3 M -$5.05 M +$17.5 M +77.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$95.8 M -$24.8 M -$3.42 M -16% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$92.4 M -$21.5 M -$5.78 M -36.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$86.6 M -$26.9 M +$4.62 M +14.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$91.2 M -$22.5 M -$1.73 M -8.33% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$89.5 M -$21.4 M -$17.8 M -504% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$71.6 M -$15.8 M -$6.94 M -78.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$64.7 M -$31.6 M -$26.3 M -496% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$38.4 M -$20.8 M -$5.23 M -33.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$33.2 M -$3.54 M +$9.78 M +73.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$43 M -$8.82 M +$3.55 M +28.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$46.5 M -$5.3 M +$10.2 M +65.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$56.7 M -$15.5 M -$2.79 M -21.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$53.9 M -$13.3 M -$216 K -1.65% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$53.7 M -$12.4 M -$13.8 M -989% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$40 M -$15.5 M +$9.39 M +37.7% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 -$49.3 M -$12.8 M +$3.88 M +23.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$53.2 M -$13.1 M +$8.51 M +39.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$61.7 M $1.39 M +$22.4 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$84.1 M -$24.9 M -$14.5 M -139% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$69.7 M -$16.6 M +$10.5 M +38.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$80.2 M -$21.6 M -$4.25 M -24.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$75.9 M -$21 M -$9.04 M -75.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$66.9 M -$10.4 M +$7.02 M +40.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$73.9 M -$27.1 M -$14.1 M -109% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$59.8 M -$17.4 M -$4.89 M -39.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$54.9 M -$12 M +$223 K +1.83% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$55.1 M -$17.4 M -$5.4 M -44.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$49.7 M -$13 M +$5.18 M +28.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$54.9 M -$12.5 M -$6.3 M -102% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$48.6 M -$12.2 M -$149 K -1.24% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$48.4 M -$12 M -$8.32 M -224% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$40.1 M -$18.2 M -$13.6 M -295% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$26.5 M -$6.18 M -$1.46 M -31.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$25.1 M -$12.1 M -$4.69 M -63.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$20.4 M -$3.71 M +$6.09 M +62.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$26.5 M -$4.59 M +$3.24 M +41.4% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$29.7 M -$4.71 M +$5.96 M +55.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$35.7 M -$7.37 M +$1.49 M +16.8% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$37.2 M -$9.8 M -$1.13 M -13.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$36 M -$7.83 M -$1.9 M -32% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$34.1 M -$10.7 M -$4.22 M -65.3% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$29.9 M -$8.86 M -$2.3 M -35.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$27.6 M -$8.66 M -$1.95 M -28.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$25.7 M -$5.94 M -$2.57 M -76.4% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$23.1 M -$6.46 M -$2.72 M -72.9% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$20.4 M -$6.56 M +$16 M +70.9% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$36.4 M -$6.72 M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$3.37 M -$1.25 M -58.7% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 -$3.73 M Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 -$22.5 M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 -$2.12 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.